SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Koichiro Miyagawa, Michihiko Shibata, Shinsuke Kumei, Tooru Matsuhashi, Masaaki Hiura, Shintaro Abe, Masaru Harada, A case of resolved hepatitis B who was observed HBV viremia transiently during HSV hepatitis immediately after steroid pulse therapy, Kanzo, 2014, 55, 1, 51

    CrossRef

  2. 2
    Brian J. McMahon, Chronic Hepatitis B Virus Infection, Medical Clinics of North America, 2014, 98, 1, 39

    CrossRef

  3. 3
    José Manuel Vaquero Barrios, Javier Redel Montero, Francisco Santos Luna, Comorbidities Impacting on Prognosis After Lung Transplant, Archivos de Bronconeumología (English Edition), 2014, 50, 1, 25

    CrossRef

  4. 4
    José Manuel Vaquero Barrios, Javier Redel Montero, Francisco Santos Luna, Comorbilidades con impacto pronóstico tras el trasplante pulmonar, Archivos de Bronconeumología, 2014, 50, 1, 25

    CrossRef

  5. 5
    Kiran Motaparthi, Vladimir Stanisic, Abby S. Van Voorhees, Mark G. Lebwohl, Sylvia Hsu, From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti–tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis, Journal of the American Academy of Dermatology, 2014, 70, 1, 178

    CrossRef

  6. 6
    M. Mikulska, L. Nicolini, A. Signori, G. Rivoli, V. Del Bono, A. M. Raiola, C. Di Grazia, A. Dominietto, R. Varaldo, A. Ghiso, A. Bacigalupo, C. Viscoli, Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome, Clinical Microbiology and Infection, 2014, 20,
  7. 7
    Su-Hyung Park, Barbara Rehermann, Immune Responses to HCV and Other Hepatitis Viruses, Immunity, 2014, 40, 1, 13

    CrossRef

  8. 8
    Françoise Lunel-Fabiani, Charles Masson, Alexandra Ducancelle, Maladies systémiques et biomédicaments : comprendre, apprécier et prévenir le risque de réactivation d’hépatite B, Revue du Rhumatisme, 2014,

    CrossRef

  9. 9
    Massimo Marignani, Alfredo Marzano, Paola Begini, Umberto Vitolo, Stefano Luminari, Alessandro Levis, Ilaria Deli, Elia Gigante, Emanuela De Santis, Gianfranco delle Fave, Bruno Monarca, Maria Christina Cox, Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey, Leukemia & Lymphoma, 2014, 1

    CrossRef

  10. 10
    Vassilios Papastergiou, Andrew K Burroughs, Emmanuel A Tsochatzis, Prognosis and treatment of patients with acute alcoholic hepatitis, Expert Review of Gastroenterology & Hepatology, 2014, 1

    CrossRef

  11. 11
    Rongjuan Pei, Sebastian Grund, Jens Verheyen, Stefan Esser, Xinwen Chen, Mengji Lu, Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies, Virology Journal, 2014, 11, 1, 9

    CrossRef

  12. 12
    Françoise Lunel-Fabiani, Charles Masson, Alexandra Ducancelle, Systemic diseases and biotherapies: Understanding, evaluating, and preventing the risk of hepatitis B reactivation, Joint Bone Spine, 2014,

    CrossRef

  13. 13
    A. Mekkaoui, Z. Benbrahim, O. Mesbahi, A. Ibrahimi, N. Aqodad, Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreuse, Journal Africain du Cancer / African Journal of Cancer, 2014, 6, 1, 47

    CrossRef

  14. 14
    Amir Shlomai, Ype P. de Jong, Charles M. Rice, Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma, Seminars in Cancer Biology, 2014,

    CrossRef

  15. 15
    Pankaj Puri, Acute Exacerbation of Chronic Hepatitis B: The Dilemma of Differentiation from Acute Viral Hepatitis B, Journal of Clinical and Experimental Hepatology, 2013, 3, 4, 301

    CrossRef

  16. 16
    Timothy M. Block, Robert Gish, Haitao Guo, Anand Mehta, Andrea Cuconati, W. Thomas London, Ju-Tao Guo, Chronic hepatitis B: What should be the goal for new therapies?, Antiviral Research, 2013, 98, 1, 27

    CrossRef

  17. 17
    Yang Tang, Li-Guang Sun, Chun-Shui Liu, Yu-Ying Li, Chun-Hui Jin, Dan Li, Ou Bai, Clinical Analysis of Stages of HBV Infection in 100 Cases of Lymphoma, Asian Pacific Journal of Cancer Prevention, 2013, 14, 2, 959

    CrossRef

  18. 18
    H.G. Kim, E.Y. Kim, Y.J. Yu, G.H. Kim, J.W. Jeong, J.H. Byeon, B.H. Chung, C.W. Yang, Comparison of Clinical Outcomes in Hepatitis B Virus–Positive Kidney Transplant Recipients With or Without Pretransplantation Antiviral Therapy, Transplantation Proceedings, 2013, 45, 4, 1374

    CrossRef

  19. 19
    Kathrine Stene-Johansen, Regine Barlinn, Diagnostikk av kronisk hepatitt B-infeksjon, Tidsskrift for Den norske legeforening, 2013, 133, 16, 1717

    CrossRef

  20. 20
    Fei W. Chen, Luke Coyle, Brett E. Jones, Venessa Pattullo, Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease, Liver International, 2013, 33, 8
  21. 21
    Eleonora Teplinsky, Derrick Cheung, Ilan Weisberg, Ramon E. A. Jacobs, Martin Wolff, James Park, Kent Friedman, Franco Muggia, Komal Jhaveri, Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature, Breast Cancer Research and Treatment, 2013, 141, 2, 167

    CrossRef

  22. 22
    Ricardo K. Magalhães, Daniela Ferreira, Marta Salgado, Isabel Pedroto, Hepatitis B Virus Reactivation After Chemotherapy in an HIV-Positive Patient, Journal of Clinical Gastroenterology, 2013, 47, 6, 565

    CrossRef

  23. 23
    Tamaki Ichiya, Jong-Hon Kang, Takeshi Matsui, Kunihiko Tsuji, Hiroyuki Maguchi, Minoru Uebayashi, Seishou Ando, Akihiro Takiyama, Toshiya Shinohara, Hepatitis B virus reactivation presented at 10 months after the last R-CHOP therapy against malignant lymphoma: A case report, Kanzo, 2013, 54, 3, 194

    CrossRef

  24. 24
    W H Y Ling, P P Soe, A S L Pang, S-C Lee, Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours, British Journal of Cancer, 2013, 108, 10, 1931

    CrossRef

  25. 25
    Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert, Intrahepatic cholestasis in common chronic liver diseases, European Journal of Clinical Investigation, 2013, 43, 10
  26. 26
    Nina Droz, Laurent Gilardin, Patrice Cacoub, Francis Berenbaum, Daniel Wendling, Bertrand Godeau, Anne-Marie Piette, Emmanuelle Dernis, Mikael Ebbo, Bruno Fautrel, Guillaume Le Guenno, Arsène Mekinian, Brigitte Bernard-Chabert, Nathalie Costedoat-Chalumeau, Elodie Descloux, Jean-Marie Michot, Sylvie Radenne, Aude Rigolet, Sophie Rivière, Jean-Luc Yvin, Vincent Thibault, Dominique Thabut, Stanislas Pol, Loïc Guillevin, Luc Mouthon, Benjamin Terrier, Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune-Mediated Inflammatory Diseases, Arthritis Care & Research, 2013, 65, 9
  27. 27
    Jun Aoki, Yuka Kowazaki, Takahiro Ohtsuki, Rumiko Okamoto, Kazuteru Ohashi, Seishu Hayashi, Hisashi Sakamaki, Michinori Kohara, Kiminori Kimura, Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation, Journal of Gastroenterology, 2013, 48, 6, 728

    CrossRef

  28. 28
    Michelle C.M. Cheung, Kosh Agarwal, Liver abnormalities in the immunosuppressed, Best Practice & Research Clinical Gastroenterology, 2013, 27, 4, 597

    CrossRef

  29. 29
    Atsushi Takahashi, Kazumichi Abe, Rie Saito, Haruyo Iwadate, Ken Okai, Fumiko Katsushima, Kyoko Monoe, Yukiko Kanno, Hironobu Saito, Hiroko Kobayashi, Hiroshi Watanabe, Hiromasa Ohira, Liver Dysfunction in Patients with Systemic Lupus Erythematosus, Internal Medicine, 2013, 52, 13, 1461

    CrossRef

  30. 30
    Bin-Wei Duan, Shi-Chun Lu, Meng-Long Wang, Jin-Ning Liu, Ping Chi, Wei Lai, Ju-Shan Wu, Qing-Liang Guo, Dong-Dong Lin, Yuan Liu, Dao-Bing Zeng, Chuan-Yun Li, Qing-Hua Meng, Hui-Guo Ding, Xin-Yue Chen, Hui-Yu Liao, Lie-Qing Ma, Yu Chen, Jing Zhang, Hai-Ping Xiang, Zhong-Ping Duan, Ning Li, Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases, Journal of Surgical Research, 2013, 183, 2, 936

    CrossRef

  31. You have free access to this content31
    Stanislas Pol, Management of HBV in immunocompromised patients, Liver International, 2013, 33,
  32. 32
    Jessica P. Hwang, Anna S.-F. Lok, Management of patients with hepatitis B who require immunosuppressive therapy, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 4, 209

    CrossRef

  33. 33
    Adnan Alatoom, M. Qasim Ansari, Jennifer Cuthbert, Multiple Factors Contribute to Positive Results for Hepatitis A Virus Immunoglobulin M Antibody, Archives of Pathology & Laboratory Medicine, 2013, 137, 1, 90

    CrossRef

  34. 34
    Yu-Chuen Huang, Chii-Ming Jiang, Yu-Jen Chen, Yu-Yawn Chen, Pectinesterase Inhibitor from Jelly Fig (Ficus awkeotsang Makino) Achene Inhibits Surface Antigen Expression by Human Hepatitis B Virus, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  35. 35
    Shinta Mizuno, Yoshiyuki Yamagishi, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Mai Katahira, Aya Sasaki, Michiie Sakamoto, Hidekazu Suzuki, Takanori Kanai, Toshifumi Hibi, Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier, Clinical Journal of Gastroenterology, 2013, 6, 2, 188

    CrossRef

  36. You have free access to this content36
    H.-S. Shiah, C.-Y. Chen, C.-Y. Dai, C.-F. Hsiao, Y.-J. Lin, W.-C. Su, J.-Y. Chang, J. Whang-Peng, P.-W. Lin, J.-D. Huang, L.-T. Chen, Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2013, 37, 1
  37. 37
    Rania A. Tohme, Lisa Bulkow, Chriss E. Homan, Susan Negus, Brian J. McMahon, Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B—Alaska, 2001–2010, Journal of Clinical Virology, 2013, 58, 2, 396

    CrossRef

  38. 38
    M. Ikeda, Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy, Japanese Journal of Clinical Oncology, 2013, 43, 1, 8

    CrossRef

  39. You have free access to this content39
    Tsunamasa Watanabe, Yasuhito Tanaka, Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy, Hepatology Research, 2013, 43, 2
  40. 40
    D. Ernst, R.E. Schmidt, T. Witte, Sekundäre Immundefizienz bei rheumatologischen Erkrankungen, Zeitschrift für Rheumatologie, 2013, 72, 7, 634

    CrossRef

  41. 41
    Chan-Juan Zou, Lang-Jing Zhu, Yan-Hua Li, Ying-Qian Mo, Dong-Hui Zheng, Jian-Da Ma, Xia Ou-Yang, Frank Pessler, Lie Dai, The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis, Clinical Rheumatology, 2013, 32, 6, 787

    CrossRef

  42. 42
    M. Mouler Rechtman, E. O. Burdelova, I. Bar-Yishay, M. Ben-Yehoyada, S. Fishman, Z. Halpern, A. Shlomai, The metabolic regulator PGC-1α links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus, Journal of Viral Hepatitis, 2013, 20, 1
  43. 43
    Kichul Shin, Hyeongap Jang, Won Mo Jang, Jin-Seok Lee, Yeong-Wook Song, Treatment of Rheumatoid Arthritis Patients with Chronic Hepatitis B: Analysis of Korean National Health Insurance Claims Data, Journal of Rheumatic Diseases, 2013, 20, 1, 24

    CrossRef

  44. 44
    J. Sperl, S. Frankova, E. Kieslichova, M. Oliverius, L. Janousek, E. Honsova, P. Trunecka, J. Spicak, Urgent Liver Transplantation for Chemotherapy-Induced HBV Reactivation: A Suitable Option in Patients Recently Treated for Malignant Iymphoma, Transplantation Proceedings, 2013, 45, 7, 2834

    CrossRef

  45. 45
    Dimitrios Vassilopoulos, Leonard H. Calabrese, Viral Hepatitis: Review of Arthritic Complications and Therapy for Arthritis in the Presence of Active HBV/HCV, Current Rheumatology Reports, 2013, 15, 4

    CrossRef

  46. 46
    Antoine Néel, Alexandra Espitia, Maëva Lefebvre, Mohamed Hamidou, Lupus érythémateux, 2013,

    CrossRef

  47. 47
    Parag Mahale, Dimitrios P. Kontoyiannis, Roy F. Chemaly, Ying Jiang, Jessica P. Hwang, Marta Davila, Harrys A. Torres, Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients, Journal of Hepatology, 2012, 57, 6, 1177

    CrossRef

  48. 48
    L. C. Claridge, C. Dobson, H. Kanji, D. Neil, J. M. Timms, A. P. Holt, Acute liver failure secondary to opportunistic viral infection in adult solid organ transplant recipients, QJM, 2012, 105, 9, 879

    CrossRef

  49. 49
    Mihály Makara, Gábor Horváth, Judit Gervain, Alajos Pár, Ferenc Szalay, László Telegdy, István Tornai, Eszter Újhelyi, Béla Hunyady, Ajánlás a B-, a C- és a D-vírus hepatitisek diagnosztikájára és antivirális kezelésére, Orvosi Hetilap, 2012, 153, 10, 375

    CrossRef

  50. 50
    Alban Deroux, Sylvie Larrat, Marie-Noelle Hilleret, Monique Baccard, Wen Qin, Gaelle Billet, Philippe Zaoui, Patrice Morand, Case report: Detection of a hepatitis B surface antigen variant emerging in an elderly patient after an ischemic cerebral vascular accident, Journal of Medical Virology, 2012, 84, 12
  51. 51
    Satoru Hagiwara, Toshiharu Sakurai, Shinichi Nishina, Kaoru Tanaka, Masafumi Ikeda, Kazuomi Ueshima, Yasunori Minami, Tatsuo Inoue, Norihisa Yada, Satoshi Kitai, Masahiro Takita, Tomoyuki Nagai, Sousuke Hayaishi, Tadaaki Arizumi, Ah-Mee Park, Hiroshi Munakata, Naoshi Nishida, Masatoshi Kudo, Characteristic Pattern of Reactivation of Hepatitis B Virus during Chemotherapy for Solid Cancers, Digestive Diseases, 2012, 30, 6, 541

    CrossRef

  52. 52
    Jonathan Moses, Naim Alkhouri, Angela Shannon, Kathy Raig, Rocio Lopez, Lara Danziger-Isakov, Ariel E Feldstein, Nizar N Zein, Robert Wyllie, Christine Carter-Kent, Hepatitis B Immunity and Response to Booster Vaccination in Children With Inflammatory Bowel Disease Treated With Infliximab, The American Journal of Gastroenterology, 2012, 107, 1, 133

    CrossRef

  53. 53
    A. Fylaktou, M. Daoudaki, V. Dimou, E. Sianou, D. Papaventsis, I. Mavrovouniotis, I. Fouzas, V. Papanikolaou, Hepatitis B Reactivation in a Renal Transplant Patient Due to a Surface Antigen Mutant Strain: A Case Report, Transplantation Proceedings, 2012, 44, 9, 2773

    CrossRef

  54. 54
    Han Hee Ryu, Eun Young Lee, Kichul Shin, In Ah Choi, Yun Jong Lee, Bin Yoo, Min-Chan Park, Yong-Beom Park, Sang-Cheol Bae, Wan Hee Yoo, Sung Il Kim, Eun Bong Lee, Yeong Wook Song, Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: A retrospective analysis of 49 cases, Clinical Rheumatology, 2012, 31, 6, 931

    CrossRef

  55. 55
    Yi-Hsiang Huang, Han-Chieh Lin, Shou-Dong Lee, Management of chemotherapy-induced hepatitis B virus reactivation, Journal of the Chinese Medical Association, 2012, 75, 8, 359

    CrossRef

  56. 56
    Dimitrios Vassilopoulos, Leonard H. Calabrese, Management of rheumatic disease with comorbid HBV or HCV infection, Nature Reviews Rheumatology, 2012, 8, 6, 348

    CrossRef

  57. 57
    Valentina Svicher, Valeria Cento, Martina Bernassola, Maria Neumann-Fraune, Formijn Van Hemert, Mengjie Chen, Romina Salpini, Chang Liu, Roberta Longo, Michela Visca, Sara Romano, Valeria Micheli, Ada Bertoli, Caterina Gori, Francesca Ceccherini-Silberstein, Cesare Sarrecchia, Massimo Andreoni, Mario Angelico, Antonella Ursitti, Alberto Spanò, Jing Maria Zhang, Jens Verheyen, Giuseppina Cappiello, Carlo Federico Perno, Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection, Antiviral Research, 2012, 93, 1, 86

    CrossRef

  58. 58
    B. Terrier, S. Pol, V. Thibault, J.-E. Gottenberg, P. Cacoub, Prise en charge du risque de réactivation du virus de l’hépatite B chez les patients traités par immunosuppresseurs et immunomodulateurs en médecine interne : données de l’enquête REACTI-B et proposition d’un algorithme de prise en charge, La Revue de Médecine Interne, 2012, 33, 1, 4

    CrossRef

  59. 59
    Jing Tan, Jingguo Zhou, Pan Zhao, Jing Wei, Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs, Clinical Rheumatology, 2012, 31, 8, 1169

    CrossRef

  60. 60
    Amanda Abramson, Alan Menter, Robert Perrillo, Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management, Journal of the American Academy of Dermatology, 2012, 67, 6, 1349

    CrossRef

  61. 61
    M.L. Manzano Alonso, I. Fernández Vázquez, Reactivación de la hepatitis B: prevención y tratamiento, Medicine - Programa de Formación Médica Continuada Acreditado, 2012, 11, 9, 568

    CrossRef

  62. 62
    Harrys A. Torres, Marta Davila, Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer, Nature Reviews Clinical Oncology, 2012, 9, 3, 156

    CrossRef

  63. 63
    Panagiotis Papamichalis, Alexis Alexiou, Maria Boulbou, George N. Dalekos, Eirini I. Rigopoulou, Reactivation of resolved hepatitis B virus infection after immunosuppression: Is it time to adopt pre-emptive therapy?, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 1, 84

    CrossRef

  64. You have free access to this content64
    Giuseppe Cabibbo, Laura Palmeri, Sergio Palmeri, Antonio Craxì, Should cirrhosis change our attitude towards treating non-hepatic cancer?, Liver International, 2012, 32, 1
  65. 65
    Ioanna Delladetsima, George V Papatheodoridis, Dina G Tiniakos, Angelos Hatzakis, Nikolaos C Tassopoulos, Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis, Histopathology, 2012, 61, 5
  66. 66
    Nada Kanaan, Benoit Kabamba, Céline Maréchal, Yves Pirson, Claire Beguin, Eric Goffin, Ziad Hassoun, Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection, Journal of Clinical Virology, 2012, 55, 3, 233

    CrossRef

  67. 67
    Dimitrios Vassilopoulos, George V Papatheodoridis, The safety of anti-TNF therapy in patients with hepatitis B and C virus infection, International Journal of Clinical Rheumatology, 2012, 7, 2, 191

    CrossRef

  68. 68
    Giuseppe Indolfi, Alessandro Nesi, Massimo Resti, Treatment of chronic hepatitis B and C in children, Future Virology, 2012, 7, 10, 955

    CrossRef

  69. 69
    Doan Y. Dao, Linda S. Hynan, He-Jun Yuan, Corron Sanders, Jody Balko, Nahid Attar, Anna S.F. Lok, R. Ann Word, William M. Lee, Two distinct subtypes of hepatitis B virus–related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels, Hepatology, 2012, 55, 3
  70. 70
    L. K. King, A. Lee, A. Anandacoomarasamy, Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B, Internal Medicine Journal, 2012, 42, 5
  71. 71
    Yeo Myeong Kim, Sook-Hyang Jeong, Jin-Wook Kim, Sang Hyub Lee, Jin Hyuk Hwang, Young Soo Park, Nayoung Kim, Jong Seok Lee, Hyun Young Kim, Dong Ho Lee, Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy, Journal of Clinical Virology, 2011, 51, 4, 241

    CrossRef

  72. 72
    H.-R. Li, J.-J. Huang, H.-Q. Guo, X. Zhang, Y. Xie, H.-L. Zhu, L.-Z. Zhai, X.-X. Pu, Y. Huang, C.-C. Guo, T.-Y. Lin, Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy, Journal of Viral Hepatitis, 2011, 18, 12
  73. 73
    Kalliopi Zachou, George N. Dalekos, Hepatitis B re-activation with rituximab therapy: treat the patient not the disease, Liver International, 2011, 31, 3
  74. 74
    Federica Toscanini, Pasqualina De Leo, Giuseppe Calcagno, Federica Malfatti, Alessandro Grasso, Marco Anselmo, Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia, Case Reports in Hepatology, 2011, 2011, 1

    CrossRef

  75. 75
    Jorge Méndez-Navarro, Kathleen E. Corey, Hui Zheng, Lydia L. Barlow, Jae Young Jang, Wenyu Lin, Hong Zhao, Run-Xuan Shao, Steven L. McAfee, Raymond T. Chung, Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy, Liver International, 2011, 31, 3
  76. 76
    Hellan Kwon, Anna S. Lok, Hepatitis B therapy, Nature Reviews Gastroenterology & Hepatology, 2011,

    CrossRef

  77. 77
    Harmit Kalia, Fabrizio Fabrizi, Paul Martin, Hepatitis B virus and renal transplantation, Transplantation Reviews, 2011, 25, 3, 102

    CrossRef

  78. 78
    Iddo Bar-Yishay, Yosef Shaul, Amir Shlomai, Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression, Liver International, 2011, 31, 3
  79. 79
    Hatef Massoumi, Paul Martin, Hui-Hui Tan, Management of chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2011, 23, 8, 642

    CrossRef

  80. 80
    Juan Muñoz-Ortego, John Lara, José Tomás Navarro Ferrando, Mujer de 21 años con fiebre, artralgias y leucocitosis, Medicina Clínica, 2011, 136, 1, 31

    CrossRef

  81. 81
    Yen-Hsuan Ni, Natural history of hepatitis B virus infection: pediatric perspective, Journal of Gastroenterology, 2011, 46, 1, 1

    CrossRef

  82. 82
    Shunsuke Mori, Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs, Modern Rheumatology, 2011, 21, 6, 621

    CrossRef

  83. 83
    Shunsuke Mori, Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs, Modern Rheumatology, 2011, 21, 6, 621

    CrossRef

  84. 84
    Yukitomo Urata, Ryoko Uesato, Dai Tanaka, Kenji Kowatari, Taisuke Nitobe, Yoshihide Nakamura, Shigeru Motomura, Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients, Modern Rheumatology, 2011, 21, 1, 16

    CrossRef

  85. 85
    Yukitomo Urata, Ryoko Uesato, Dai Tanaka, Kenji Kowatari, Taisuke Nitobe, Yoshihide Nakamura, Shigeru Motomura, Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients, Modern Rheumatology, 2011, 21, 1, 16

    CrossRef

  86. 86
    Akihiro Tamori, Tatsuya Koike, Hitoshi Goto, Shigeyuki Wakitani, Masahiro Tada, Hiroyasu Morikawa, Masaru Enomoto, Masaaki Inaba, Tatsuya Nakatani, Masayuki Hino, Norifumi Kawada, Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts, Journal of Gastroenterology, 2011, 46, 4, 556

    CrossRef

  87. 87
    Masaaki Watanabe, Akitaka Shibuya, Yuhko Tsunoda, Mikio Danbara, Ryuji Ishii, Manabu Ohsaka, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Ryouichi Horie, Masaaki Higashihara, Wasaburo Koizumi, Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection, Liver International, 2011, 31, 3
  88. 88
    Florence Wong, Renal Diseases and the Liver, Clinics in Liver Disease, 2011, 15, 1, 39

    CrossRef

  89. 89
    Ilaria Lenci, Giuseppe Tisone, Daniele Di Paolo, Fabio Marcuccilli, Laura Tariciotti, Marco Ciotti, Valentina Svicher, Carlo Federico Perno, Mario Angelico, Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence, Journal of Hepatology, 2011, 55, 3, 587

    CrossRef

  90. 90
    Dimitrios Vassilopoulos, Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes, European Journal of Internal Medicine, 2011, 22, 6, 572

    CrossRef

  91. 91
    Tatyana A. Shamliyan, James R. Johnson, Roderick MacDonald, Aasma Shaukat, Jian-Min Yuan, Robert L. Kane, Timothy J. Wilt, Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection, Journal of General Internal Medicine, 2011, 26, 3, 326

    CrossRef

  92. You have free access to this content92
    Bruno Roche, Didier Samuel, The difficulties of managing severe hepatitis B virus reactivation, Liver International, 2011, 31,
  93. 93
    B. Terrier, P. Cacoub, Virus de l’hépatite B, manifestations extrahépatiques immunologiques et risque de réactivation virale, La Revue de Médecine Interne, 2011, 32, 10, 622

    CrossRef

  94. 94
    Syed-Mohammed R. Jafri, Anna Suk-Fong Lok, Antiviral Therapy for Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 425

    CrossRef

  95. 95
    Atsushi Takahashi, Kazumichi Abe, Junko Yokokawa, Haruyo Iwadate, Hiroko Kobayashi, Hiroshi Watanabe, Atsushi Irisawa, Hiromasa Ohira, Clinical features of liver dysfunction in collagen diseases, Hepatology Research, 2010, 40, 11
  96. 96
    Masaaki Watanabe, Akitaka Shibuya, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Wasaburo Koizumi, Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients, European Journal of Internal Medicine, 2010, 21, 4, 333

    CrossRef

  97. 97
    I-Cheng Lee, Yi-Hsiang Huang, Chi-Jen Chu, Pui-Ching Lee, Han-Chieh Lin, Shou-Dong Lee, Hepatitis B Virus Reactivation After 23 Months of Rituximab-based Chemotherapy in an HBsAg-negative, Anti-HBs-positive Patient With Follicular Lymphoma, Journal of the Chinese Medical Association, 2010, 73, 3, 156

    CrossRef

  98. 98
    D. Meyer-Olson, K. Hoeper, R.E. Schmidt, Infektionskomplikationen unter Biologika-Therapie bei Patienten mit rheumatoider Arthritis, Zeitschrift für Rheumatologie, 2010, 69, 10, 879

    CrossRef

  99. 99
    Hank S. Wang, Steven-Huy B. Han, Management of Hepatitis B in Special Patient Populations, Clinics in Liver Disease, 2010, 14, 3, 505

    CrossRef

  100. 100
    F. B. Hollinger, G. Sood, Occult hepatitis B virus infection: a covert operation, Journal of Viral Hepatitis, 2010, 17, 1
  101. 101
    Swati Sinha, Manoj Kumar, Pregnancy and chronic hepatitis B virus infection, Hepatology Research, 2010, 40, 1
  102. 102
    Jefrey Salek, Janice Byrne, Terry Box, Nicola Longo, Norman Sussman, Recurrent liver failure in a 25-year-old female, Liver Transplantation, 2010, 16, 9
  103. 103
    Dimitrios Vassilopoulos, Spilios Manolakopoulos, Rheumatic manifestations of hepatitis, Current Opinion in Rheumatology, 2010, 22, 1, 91

    CrossRef

  104. 104
    Keiichi Fujiwara, Shin Yasui, Koichiro Okitsu, Yutaka Yonemitsu, Shigeto Oda, Osamu Yokosuka, The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B, Journal of Gastroenterology, 2010, 45, 12, 1255

    CrossRef

  105. 105
    Simona Urbani, Francesco Fagnoni, Gabriele Missale, Massimo Franchini, The role of anti-core antibody response in the detection of occult hepatitis B virus infection, Clinical Chemistry and Laboratory Medicine, 2010, 48, 1

    CrossRef

  106. 106
    Manuel Ramos-Casals, Therapy: Are TNF blockers safe for patients with hepatitis B virus infection?, Nature Reviews Rheumatology, 2010, 6, 11, 618

    CrossRef

  107. 107
    Jay H. Hoofnagle, ChemInform Abstract: Reactivation of Hepatitis B, ChemInform, 2009, 40, 50
  108. 108
    Shannan R. Tujios, William M. Lee, Acute Liver Failure,
  109. 109
    Amer Skopic, Maria H. Sjogren, Acute viral hepatitis,
  110. 110
    Cui Li Lin, Chelsea Q. Xu, Jack R. Wands, Clinical and Diagnostic Aspects of Viral Hepatitis,
  111. 111
    Niharika Samala, Preet Bagi, Theo Heller, Steven Pavletic, Hepatic Complications of Hematopoietic Stem Cell Transplantation,
  112. 112
    Anna S. F. Lok, Hepatitis B,
  113. 113
    Anna S. F. Lok, Francesco Negro, Hepatitis B and D,
  114. 114
    Experimental and Clinical Transplantation,

    CrossRef